INFOGRAPHIC: The changing face of the orthopedic market
This article was originally published in Clinica
Executive Summary
Consolidation is the current buzzword in the orthopedic sector, as the M&A merry-go-round continues. There have been several big-bucks deals in recent years, starting with Johnson & Johnson’s $21bn acquisition of Synthes, agreed in 2011 (and finally completed in 2012). This year, the trend has continued with Zimmer’s $13bn purchase of Biomet, agreed in April.